Again, GM-CSF application had no influence on the production of tetanus-specific antibodies, as there was no difference in tetanus-specific antibody levels between the placebo- and the GM-CSF-treated group in both, young and aged mice (Fig. 5b). Here, CSF2 is linked to tetanus.